BeOne Medicines
ONC
#642
Rank
HK$294.27 B
Marketcap
HK$2,659
Share price
-2.75%
Change (1 day)
50.42%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): HK$5.15

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is HK$5.08. In 2024 the company made an earnings per share (EPS) of -HK$48.75.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$5.15-110.56%
2024-HK$48.75
2022-HK$152.3528.21%
2021-HK$118.83-19.96%
2020-HK$148.4720.81%
2019-HK$122.8931.52%
2018-HK$93.44417.57%
2017-HK$18.05-37.16%
2016-HK$28.73158.95%
2015-HK$11.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-HK$1.88-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$7.42-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA